Close Menu

NEW YORK – The legal battle over the ownership rights to foundational patents for CRISPR-Cas9 technology took a nasty turn this week after the University of California and its co-plaintiffs in the case accused the Broad Institute's Feng Zhang and his collaborator Neville Sanjana of making "untrue" and "materially false" declarations in the Broad's original patent applications.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.